BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17123281)

  • 1. Model for end-stage liver disease (MELD) exception for familial amyloidotic polyneuropathy.
    Pomfret E; Gish RG; Brandhagen D
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S100-1. PubMed ID: 17123281
    [No Abstract]   [Full Text] [Related]  

  • 2. Model for end-stage liver disease (MELD) exception guidelines.
    Wiesner R; Lake JR; Freeman RB; Gish RG
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S85-7. PubMed ID: 17123285
    [No Abstract]   [Full Text] [Related]  

  • 3. Model for end-stage liver disease (MELD) exception for polycystic liver disease.
    Arrazola L; Moonka D; Gish RG; Everson GT
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S110-1. PubMed ID: 17123287
    [No Abstract]   [Full Text] [Related]  

  • 4. Model for end-stage liver disease (MELD) exception for severe pruritus.
    Washburn WK; Gish RG
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S119. PubMed ID: 17123292
    [No Abstract]   [Full Text] [Related]  

  • 5. Model for end-stage liver disease (MELD) exception for unusual metabolic liver diseases.
    McDiarmid S; Gish RG; Horslen S; Mazariegos GV
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S124-7. PubMed ID: 17123278
    [No Abstract]   [Full Text] [Related]  

  • 6. Model for end-stage liver disease (MELD) exception for hepatic encephalopathy.
    Ham J; Gish RG; Mullen K
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S102-4. PubMed ID: 17123294
    [No Abstract]   [Full Text] [Related]  

  • 7. Model for end-stage liver disease (MELD) exception for ascites.
    Biggins SW; Colquhoun S; Gish RG; Runyon BA
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S88-90. PubMed ID: 17123288
    [No Abstract]   [Full Text] [Related]  

  • 8. Model for end-stage liver disease (MELD) exception for cystic fibrosis.
    Horslen S; Sweet S; Gish RG; Shepherd R
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S98-9. PubMed ID: 17123272
    [No Abstract]   [Full Text] [Related]  

  • 9. Model for end-stage liver disease (MELD) exception for Budd-Chiari syndrome.
    Washburn WK; Gish RG; Kamath PS
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S93-4. PubMed ID: 17123293
    [No Abstract]   [Full Text] [Related]  

  • 10. Model for end-stage liver disease (MELD) exception for primary hyperoxaluria.
    Horslen S; Gish RG; McDonald R
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S117-8. PubMed ID: 17123291
    [No Abstract]   [Full Text] [Related]  

  • 11. Model for end-stage liver disease (MELD) exception for hereditary hemorrhagic telangiectasia.
    Garcia-Tsao G; Gish RG; Punch J
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S108-9. PubMed ID: 17123286
    [No Abstract]   [Full Text] [Related]  

  • 12. Model for end-stage liver disease (MELD) exception small-for-size syndrome.
    Sheiner P; Belghiti J; Gish RG; Miller C
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S120-1. PubMed ID: 17123277
    [No Abstract]   [Full Text] [Related]  

  • 13. Model for end-stage liver disease (MELD) exception for bacterial cholangitis.
    Gores GJ; Gish RG; Shrestha R; Wiesner RH
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S91-2. PubMed ID: 17123280
    [No Abstract]   [Full Text] [Related]  

  • 14. Model for end-stage liver disease (MELD) exception for portopulmonary hypertension.
    Krowka MJ; Fallon MB; Mulligan DC; Gish RG
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S114-6. PubMed ID: 17123283
    [No Abstract]   [Full Text] [Related]  

  • 15. Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome.
    Fallon MB; Mulligan DC; Gish RG; Krowka MJ
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S105-7. PubMed ID: 17123282
    [No Abstract]   [Full Text] [Related]  

  • 16. Model for end-stage liver disease (MELD) exception for uncommon hepatic tumors.
    Punch J; Gish RG
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S122-3. PubMed ID: 17123279
    [No Abstract]   [Full Text] [Related]  

  • 17. Model for end-stage liver disease (MELD) exception for portal hypertensive gastrointestinal bleeding.
    Sheiner P; Gish RG; Sanyal A
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S112-3. PubMed ID: 17123290
    [No Abstract]   [Full Text] [Related]  

  • 18. Familial amyloid polyneuropathy and liver transplantation.
    Monteiro E; Freire A; Barroso E
    J Hepatol; 2004 Aug; 41(2):188-94. PubMed ID: 15288465
    [No Abstract]   [Full Text] [Related]  

  • 19. Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia.
    Gores GJ; Gish RG; Sudan D; Rosen CB;
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S95-7. PubMed ID: 17123289
    [No Abstract]   [Full Text] [Related]  

  • 20. The model for end-stage liver disease comes of age.
    Freeman RB
    Clin Liver Dis; 2007 May; 11(2):249-63. PubMed ID: 17606205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.